EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients

Isabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie, Sushmita Paul, Franziska Czubayko, Anke Mittelstädt iD, Ann-Kathrin Koch, Alara Karabiber, Frederik J Hansen iD, Lisa-Sophie Arnold, Nadine Weisel, Susanne Merkel iD und 6 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26072875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Isabelle Kuchenreuther und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Member 14, Carcinoma, Pancreatic Ductal, Monocytes, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation and BMBF, German Research Foundation, BMBF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is aggressive, with a 5-year survival rate of only 12.8%, and its increasing incidence in Western countries highlights the urgent need for better early-stage detection and treatment methods. Early diagnosis significantly improves the chances of survival, but non-specific symptoms and undetectable precursor lesions pose a major challenge. To date, there are no reliable screening tools to detect PDAC at an early stage. Herpesvirus entry mediator (HVEM) has already been proposed as a prognostic marker in numerous cancer types. Therefore, we investigated the role of HVEM in PDAC. Flow cytometry was used to analyze HVEM expression in immune cells and its inhibitory receptors (CD160 and BTLA) on T-cells, as well as its subsets in the peripheral blood of 57 diagnosed PDAC patients and 17 clinical controls. In addition, survival analyses were performed within the PDAC cohort, changes in HVEM expression were analyzed in relation to clinicopathological parameters, and a correlation analysis between HVEM expression and cytokine levels of IL-6 and IL-10 was conducted. Furthermore, HVEM expression on monocytes and their subsets was evaluated as a potential prognostic marker and compared with the prognostic utility of CA19-9. We found that HVEM expression is significantly elevated on immune cells, particularly on monocytes (p < 0.0001) and their subsets, in PDAC patients, and is associated with reduced survival (p = 0.0067) and clinicopathological features such as perineural, lymphovascular, and vascular invasion. Moreover, HVEM-expressing monocytes demonstrated superior predictive value compared to CA19-9, highlighting their potential as part of a combined screening tool for PDAC. In conclusion, HVEM on monocytes could serve as a novel prognostic marker for PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Tumor Necrosis Factor, Member 14Carcinoma, Pancreatic DuctalMonocytesPancreatic NeoplasmsHumansFemaleMaleMiddle AgedPrognosisAgedBiomarkers, TumorAntigens, CDReceptors, ImmunologicInterleukin-10AdultInterleukin-6GPI-Linked Proteins

Stichwörter der Autor:innen

HVEMPDACbiomarkersinhibitory molecules

Substanzen

Receptors, Tumor Necrosis Factor, Member 14Biomarkers, TumorTNFRSF14 protein, humanBTLA protein, humanAntigens, CDReceptors, ImmunologicInterleukin-10CD160 protein, humanInterleukin-6GPI-Linked Proteins

Autor:innen und Institutionen

  • Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Faculty of Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
  • Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, 91054 Erlangen, Germany.
  • Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany.

ORCID-Profile: Anke Mittelstädt, Frederik J Hansen, Susanne Merkel, Christian Krautz, Julio Vera, Georg F Weber, Paul David

Förderung

  • German Research Foundation and BMBF
  • German Research Foundation
  • BMBF
  • BMBF KI-VesD
  • BMBF KI-VesD-2

Zitieren

APA

Kuchenreuther, I., Clausen, F. N., Mazurie, J., Paul, S., Czubayko, F., Mittelstädt, A., Koch, A. K., Karabiber, A., Hansen, F. J., Arnold, L. S., Weisel, N., Merkel, S., Brunner, M., Krautz, C., Vera, J., Grützmann, R., Weber, G. F., & David, P. (2025). Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072875

Vancouver

Kuchenreuther I, Clausen FN, Mazurie J, Paul S, Czubayko F, Mittelstädt A, et al. Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072875

BibTeX
@article{Kuchenreuther2025,
  author = {Kuchenreuther, Isabelle and Clausen, Finn-Niklas and Mazurie, Johanne and Paul, Sushmita and Czubayko, Franziska and Mittelstädt, Anke and Koch, Ann-Kathrin and Karabiber, Alara and Hansen, Frederik J and Arnold, Lisa-Sophie and Weisel, Nadine and Merkel, Susanne and Brunner, Maximilian and Krautz, Christian and Vera, Julio and Grützmann, Robert and Weber, Georg F and David, Paul},
  title = {Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26072875}
}
Kostenlos starten →